IndraLab

Statements


BCL2 activates USP9X. 1 / 1
| 1

reach
"Treatment with TIC10 and ONC201 and concomitant inhibition of Bcl-2 and Bcl-xL depletes the Mcl-1 chaperone Bag3 and the deubiquitinase Usp9X."